van Hoek, Bart

Kerbert, Annarein J C; Reverter, Enric; Verbruggen, Lara; Tieleman, Madelon; Navasa, Miguel; Mertens, Bart J A; Rodríguez-Tajes, Sergio; de Vree, Marleen; Metselaar, Herold J; Chiang, Fang W T; Verspaget, Hein W; van Hoek, Bart; Bosch, Jaime; Coenraad, Minneke J (2018). Impact of hepatic encephalopathy on liver transplant waiting list mortality in regions with different transplantation rates. Clinical transplantation, 32(11), e13412. Wiley-Blackwell 10.1111/ctr.13412

Karkampouna, Sofia; van der Helm, Danny; Gray, Peter C; Chen, Lanpeng; Klima, Irena; Grosjean, Joël; Burgmans, Mark C; Farina-Sarasqueta, Arantza; Snaar-Jagalska, Ewa B; Keogh-Stroka, Deborah M.; Terracciano, Luigi; van Hoek, Bart; Schaapherder, Alexander F; Osanto, Susan; Thalmann, George; Verspaget, Hein W; Coenraad, Minneke J; Kruithof-de Julio, Marianna (2018). CRIPTO promotes an aggressive tumour phenotype and resistance to treatment in hepatocellular carcinoma. Journal of pathology, 245(3), pp. 297-310. Wiley 10.1002/path.5083

Manns, Michael; Samuel, Didier; Gane, Edward J; Mutimer, David; McCaughan, Geoff; Buti, Maria; Prieto, Martín; Calleja, José Luis; Peck-Radosavljevic, Markus; Müllhaupt, Beat; Agarwal, Kosh; Angus, Peter; Yoshida, Eric M; Colombo, Massimo; Rizzetto, Mario; Dvory-Sobol, Hadas; Denning, Jill; Arterburn, Sarah; Pang, Phillip S; Brainard, Diana; ... (2016). Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial. Lancet infectious diseases, 16(6), pp. 685-697. Elsevier 10.1016/S1473-3099(16)00052-9